Wird geladen...
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
Gespeichert in:
| Veröffentlicht in: | Indian J Dermatol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601460/ https://ncbi.nlm.nih.gov/pubmed/26538739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.164447 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|